Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q2 EPS by 34c

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q2 EPS of ($1.07), $0.34 worse than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.

You May Also Be Interested In

• Intel (INTC) PT Lowered to $92 at Mizuho
• After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
• Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance